Dr. Kelsey Brose MD
Assistant Professor Hematological OncologyResearch Area(s)
- Hemophilia and other inherited bleeding disorders
- Venous thrombosis
About
Dr. Kelsey Brose is a hematologist at the Saskatoon Cancer Centre and an Assistant Professor in the College of Medicine at the University of Saskatchewan. He obtained his medical school training at the University of Alberta (2003), Internal Medicine Residency at the University of Saskatchewan (2006), and Hematology fellowship at Queen’s University (2008).
Teaching/Education
- USask Undergraduate Medical Education - Hematology/Oncology Module Director
- USask Undergraduate Medical Education - Foundations Course Co-Chair for Assessment
- Royal College of Physicians and Surgeons of Canada Examination Board Chair
Clinical Interests
- Medical education and assessment
- Inherited bleeding disorders, including hemophilia and von Willebrand disease
Selected Publications
- Rayner M, Brose K. Venous Thromboembolism Following COVID-19 Vaccination in Patients with Hereditary Protein S Deficiency. J Hematol 2024, 13(3), 125-127.
- Tupper SM, Nilson J, King J, Downe J, Hodgson N, Schlosser T, Brose K. Development and clinical feasibility testing of the Pain Treatment Planning Questionnaire. J Haem Pract 2020, 7(1). doi:10.17225/jhp00155.
- Tupper SM, Nilson J, King J, Brose K, Hodgson N, Schlosser T, Lovas O. A new tool to improve clinical communication about pain, Pain Treatment Planning Questionnaire: results from a randomized controlled trial. Oral poster presented at: World Federation of Hemophilia 33rd World Congress. 2018, May 20; Glasgow, Scotland.
- Prokopchuk-Gauk, O., Rosin, M., Mycyk, T., Lim, H., & Brose, K. (2016, Sep). Dual-Route tranexamic acid to reduce blood loss in coronary artery bypass graft surgery: a randomized controlled trial. Canadian Journal of Anesthesia, 63(9), 1110-1111.
- Minuk, L., Jackson, S., Poon, M., Dilworth, E., Brose, K., Card, R., . . . Louzada, M. (2015, November). Cardiovascular disease (CVD) inCanadians with haemophilia: Age-Related CVD in Haemophilia Epidemiological Research (ARCHER study). Haemophilia, 21(6), 736-741.
- Prokopchuk-Gauk, O., & Brose, K. (2015, December). Tranexamic Acid to Treat Life-Threatening Hemorrhage in Prostate Cancer Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis. Cureus, 7(12), e428.
- Tupper, S., Sims, M., Nilson, J., Brose, K., Card, R., Schlosser, T., . . . Buehler, C. (2014, May). Pain management: Do we offer appropriate care for men with pain due to hemophilic arthropathy? Haemophilia, Supplement 3, 155.
- Jackson, S., Yang, M., Bucevska, M., Brose, K., Webert, K., Minuk, L., . . . Poon, M. (2012, September). Patterns of factor concentrate prophylaxis in adults with severe hemophilia: A multicentre Canadian study: LB002. Haemophilia, 18(5), 831.
- Brose, K., & Lee, A. (2008, January). Cancer-associated thrombosis: prevention and treatment. Current Oncology, 15(Supplement 1), S58-67.